Volume : 09, Issue : 02, February – 2022

Title:

16.FORMULATION DEVELOPMENT AND EVALUATION OF FAST DISSOLVING TABLETS OF CETIRIZINE HYDROCHLORIDE

Authors :

Ram Krishna Shukla*, Nilesh Jain, Dr. R.B. Goswami

Abstract :

Recent developments in fast dissolving tablets have brought convenience in dosing to pediatric and elderly patients who have trouble in swallowing tablets. Cetirizine HCl is a potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria and pollen-induced asthma. In the present study an attempt has been made to prepare fast dissolving tablets of cetirizine HCl in the oral cavity with enhanced dissolution rate. The concept of formulating fast dissolving tablets containing cetirizine HCl offers a suitable and practical approach in serving desired objective of faster disintegration and dissolution characteristics with increased bioavailability. Fast dissolving tablets of cetirizine HCl were prepared by direct compression methods and blend was evaluated for the pre-compression parameters such as bulk density, compressibility, angle of repose etc. The tablets were prepared by using croscarmellose sodium and sodium starch glycolate as superdisintegrants in different concentration along with magnesium stearate microcrystalline cellulose and talc. Total six formulations were prepared and evaluated for hardness, friability, weight variation, content uniformity, wetting time, water absorption ratio, disintegration time and invitro drug release. In-vitro dissolution studies are performed by using phosphate buffer pH 6.8 at 75 rpm by paddle method. Overall, the formulation F5 containing of croscarmellose sodium was found to be promising and has shown a disintegration time 45±2sec. Thus results conclusively demonstrated successful masking of taste and fastest disintegration of the formulated tablets in oral cavity.
Keywords: Cetirizine HCl, Fast dissolving tablets, Direct compression, Superdisintegrants, Pre-compression

Cite This Article:

Please cite this article in press Ram Krishna Shukla et al, Formulation Development And Evaluation Of Fast Dissolving Tablets Of Cetirizine Hydrochloride., Indo Am. J. P. Sci, 2022; 09(2).

Number of Downloads : 10

References:

1. J. Balasubramaniam, K. Bindu, V. U. Rao, D. Ray, R. Haldar, and A. W. Brzeczko, “Effect of superdisintegrants on dissolution of cationic drugs,” Dissolution Technologies, vol. 15, no. 2, pp. 18– 25, 2008.
2. S. Avulapati, A. K. Roy, K. R. Shashidhar, and T. Ugendarreddy, “Formulation and evaluation of taste masked and fast disintegrating Losartan Potassium tablets,” International Journal of Drug Development and Research, vol. 3, no. 1, pp. 45–51, 2011.
3. G. Y. Narmada, K. Mohini, B. P. Rao, D. X. P. Gowrinath, and K. S. Kumar, “Formulation, evaluation and optimization of fast dissolving tablets containing amlodipine besylate by sublimation method,” Ars Pharmaceutica, vol. 50, no. 3, pp. 129– 144, 2009.
4. D. Shukla, S. Chakraborty, S. Singh, and B. Mishra, “Mouth dissolving tablets II: an overview of evaluation techniques,” Scientia Pharmaceutica, vol. 77, no. 2, pp. 327–341, 2009.
5. S. Corveleyn and J. P. Remon, “Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochlorothiazide as a model drug,” International Journal of Pharmaceutics, vol. 152, no. 2, pp. 215–225, 1997.
6. A. K. Nayak and K. Manna, “Current developments in orally disintegrating tablet technology,” Journal of Pharmaceutical Education and Research, vol. 2, no. 1, pp. 21–34, 2011.
7. S. A. Sreenivas, P. M. Dandagi, A. P. Gadad et al., “Orodispersible tablet: new-fanged drug delivery system-a review,” Indian Journal of Pharmaceutical Education and Research, vol. 39, no. 4, pp. 177–181, 2005.
8. D. Bhowmik, B. Chiranjib, Krishnakanth, Pankaj, and R. M. Chandira, “Fast dissolving tablet: an overview,” Journal of Chemical and Pharmaceutical Research, vol. 1, no. 1, pp. 163–177, 2009.
9. S. B. Jadhav, D. R. Kaudewar, G. S. Kaminwar, A. B. Jadhav, R. V. Kshirsagar, and D. M. Sakarkar, “Formulation and evaluation of dispersible tablets of diltiazem hydrochloride,” International Journal of PharmTech Research, vol. 3, no. 3, pp. 1314–1321, 2011.
10. K. D. Tripathi, Essential of Medical Pharmacology, Jaypee Brothers Medical Publisher, New Delhi, India, 6th edition, 2008.
11. Gautam SP, Rai JP, Billshaiya U, Jain N, Vikram P, Jain DK. Formulation and evaluation of mouth dissolving tablet of loperamide. Int J Pharm Sci Res. 2013; 4(5): 1782-1788.
12. Pandey SP, Khan MA, Dhote V, Dhote K, Jain DK. Formulation Development of Sustained Release Matrix Tablet Containing Metformin Hydrochloride and Study of Various Factors Affecting Dissolution Rate. Sch Acad J Pharm 2019; 8 (3): 57–73.
13. Patel P, Rai JP, Jain DK, Banweer J. Formulation, development and evaluation of cefaclor extended release matrix tablet. Int J Pharm Pharm Sci 2012; 4(4): 355-357.